AstraZeneca ($AZN) announced an update on their ongoing clinical study. Study Overview – AstraZeneca is launching a phase II, single‑arm trial ...
Annovis Bio Inc ($ANVS) announced an update on their ongoing clinical study. Study Overview Annovis Bio Inc. is launching a long-term safety study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback